Kinder Morgan
KMI
31.82
-0.34
-1.06%
Kinder Morgan
US · KMI
#338 by market cap
Listed 1970
31.82
-0.34
-1.06%
Live - 5344 symbols - heartbeat 243s ago
· 2026-10-08 08:04
Pre-market
32.21
+1.23%
After-hours
31.79
-0.09%
Overnight
31.82
0.00%
- Market cap
- 70.86B
- P/E (TTM)i
- 20.53
- P/Bi
- 2.24
- EPSi
- 1.37
- Div yieldi
- 3.69%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on KMI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.28, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.17% YoY
Margins
- Gross margin
- 52.87%
- Operating margin
- 27.89%
- Net margin
- 17.95%
Key ratios & quality
- Enterprise valuei
- 102.58B
- PEG ratioi
- 3.29
- Altman Z-Scorei
- 1.28
PEG uses trailing P/E against the 3-year net income growth rate (6.25%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.14B | 13.21B | 11.70B | 16.61B | 19.20B | 15.33B | 15.10B | 16.94B |
| Gross profit | 7.43B | 7.54B | 6.99B | 7.98B | 7.76B | 8.15B | 8.41B | 8.96B |
| Selling & admin expenses | 601.00M | 590.00M | 648.00M | 655.00M | 637.00M | 668.00M | 712.00M | 744.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 3.96B | 3.93B | 3.49B | 4.54B | 4.07B | 4.26B | 4.38B | 4.72B |
| Pretax profit | 2.51B | 3.17B | 661.00M | 2.22B | 3.34B | 3.20B | 3.41B | 3.99B |
| Tax | 587.00M | 926.00M | 481.00M | 369.00M | 710.00M | 715.00M | 687.00M | 832.00M |
| Net profit | 1.92B | 2.24B | 180.00M | 1.85B | 2.63B | 2.49B | 2.72B | 3.16B |
| Basic EPS | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.66 | 0.96 | 0.05 | 0.78 | 1.12 | 1.06 | 1.17 | 1.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.24B | 4.04B | 4.15B | 4.51B | 4.83B | 4.48B |
| Gross profit | 2.16B | 2.22B | 2.14B | 2.44B | 2.45B | 2.45B |
| Selling & admin expenses | 187.00M | 188.00M | 183.00M | 186.00M | 184.00M | 192.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.15B | 1.15B | 1.06B | 1.36B | 1.44B | 1.35B |
| Pretax profit | 929.00M | 919.00M | 839.00M | 1.31B | 1.29B | 1.17B |
| Tax | 186.00M | 177.00M | 185.00M | 284.00M | 287.00M | 272.00M |
| Net profit | 743.00M | 742.00M | 654.00M | 1.02B | 1.00B | 894.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.32 | 0.32 | 0.28 | 0.45 | 0.44 | 0.39 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 5.72B | 3.24B | 3.20B | 3.83B | 3.80B | 2.54B | 2.52B | 2.75B |
| Cash & ST investments | 3.28B | 1.11B | 1.18B | 1.14B | 745.00M | 83.00M | 88.00M | 63.00M |
| Inventory | 385.00M | 371.00M | 348.00M | 562.00M | 634.00M | 525.00M | 555.00M | 574.00M |
| Total assets | 78.87B | 74.16B | 71.97B | 70.42B | 70.08B | 71.02B | 71.41B | 72.75B |
| Total current liabilities | 7.56B | 5.10B | 5.07B | 5.82B | 6.93B | 7.22B | 5.10B | 4.32B |
| Short-term debt | 3.39B | 2.38B | 2.56B | 2.65B | 3.39B | 4.05B | 2.01B | 1.23B |
| Long-term debt | 33.73B | 31.81B | 32.02B | 30.56B | 28.18B | 27.85B | 29.66B | 30.56B |
| Total liabilities | 43,669,000,000.00 | 39,268,000,000.00 | 39,407,000,000.00 | 38,495,000,000.00 | 37,964,000,000.00 | 39,291,000,000.00 | 39,540,000,000.00 | 40,299,000,000.00 |
| Total equity | 35.20B | 34.89B | 32.57B | 31.92B | 32.11B | 31.73B | 31.87B | 32.45B |
| Retained earnings | -7.72B | -7.69B | -9.94B | -10.60B | -10.55B | -10.69B | -10.63B | -10.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.58B | 2.49B | 2.43B | 2.75B | 2.71B | 2.59B |
| Cash & ST investments | 80.00M | 82.00M | 71.00M | 63.00M | 72.00M | 89.00M |
| Inventory | 577.00M | 560.00M | 560.00M | 574.00M | 593.00M | 565.00M |
| Total assets | 72.32B | 72.37B | 72.32B | 72.75B | 73.07B | 74.06B |
| Total current liabilities | 5.78B | 3.63B | 3.85B | 4.32B | 5.18B | 5.65B |
| Short-term debt | 3.04B | 788.00M | 1.08B | 1.23B | 2.19B | 2.44B |
| Long-term debt | 29.86B | 31.76B | 31.39B | 30.56B | 29.76B | 29.70B |
| Total liabilities | 40,392,000,000.00 | 40,290,000,000.00 | 40,283,000,000.00 | 40,299,000,000.00 | 40,489,000,000.00 | 41,183,000,000.00 |
| Total equity | 31.93B | 32.08B | 32.03B | 32.45B | 32.58B | 32.88B |
| Retained earnings | -10.56B | -10.50B | -10.52B | -10.18B | -9.86B | -9.66B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 5.04B | 4.75B | 4.55B | 5.71B | 4.97B | 6.49B | 5.64B | 5.92B |
| Depreciation & amortization | 2.30B | 2.41B | 2.16B | 2.14B | 2.19B | 2.25B | 2.35B | 2.45B |
| Free cash flow | 2.14B | 2.48B | 2.84B | 4.43B | 3.35B | 4.17B | 3.01B | 2.89B |
| Dividends paid | -1.77B | -2.17B | -2.44B | -2.53B | -2.50B | -2.53B | -2.56B | -2.60B |
| Stock buybacks / issuance | -273.00M | -2.00M | -50.00M | 0 | -368.00M | -522.00M | -7.00M | 0 |
| Ending cash balance | 3.33B | 209.00M | 1.21B | 1.15B | 794.00M | 96.00M | 214.00M | 109.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.16B | 1.65B | 1.41B | 1.69B | 1.49B | 1.96B |
| Depreciation & amortization | 610.00M | 616.00M | 609.00M | 618.00M | 633.00M | 620.00M |
| Free cash flow | 396.00M | 1.00B | 621.00M | 872.00M | 687.00M | 978.00M |
| Dividends paid | -642.00M | -654.00M | -654.00M | -654.00M | -654.00M | -665.00M |
| Stock buybacks / issuance | 0 | 0 | 0 | 0 | -- | -- |
| Ending cash balance | 295.00M | 197.00M | 133.00M | 109.00M | 180.00M | 119.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.38 | 6.46 | 0.33 | 5.69 | 8.24 | 7.79 | 8.54 | 9.86 |
| ROA %i | 1.87 | 2.85 | 0.15 | 2.49 | 3.61 | 3.37 | 3.65 | 4.22 |
| ROIC %i | 2.07 | 3.14 | 0.16 | 2.72 | 4.01 | 3.81 | 4.18 | 4.86 |
| 5-year avg ROE %i | 2.20 | 2.62 | 2.56 | 3.38 | 5.02 | 5.70 | 6.11 | 8.02 |
| EBIT margin %i | 28.00 | 29.76 | 29.85 | 27.33 | 21.01 | 27.70 | 29.03 | 27.89 |
| FCF / sales %i | 14.98 | 18.76 | 24.30 | 26.65 | 17.43 | 27.04 | 19.91 | 17.07 |
| Current ratioi | 0.76 | 0.63 | 0.63 | 0.66 | 0.55 | 0.35 | 0.49 | 0.64 |
| Quick ratioi | 0.63 | 0.49 | 0.49 | 0.47 | 0.37 | 0.23 | 0.31 | 0.41 |
| Debt / assetsi | 47.06 | 46.09 | 48.04 | 47.16 | 45.05 | 44.91 | 44.35 | 43.69 |
| LT debt / equityi | 100.14 | 94.26 | 101.86 | 99.16 | 91.68 | 91.88 | 97.15 | 98.06 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -0.60 | 0.38 | -5.14 | 5.50 | 13.28 | 9.44 | -3.13 | -4.09 |
| Net income CAGR (3Y) %i | 85.27 | 45.70 | -13.36 | 3.50 | 5.18 | 171.86 | 13.57 | 6.25 |
| FCF CAGR (3Y) %i | 14.71 | 9.72 | 26.24 | 27.44 | 10.53 | 13.66 | -12.11 | -4.76 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.43 | 8.86 | 8.87 | 9.86 | 10.65 | 11.05 |
| ROA %i | 3.59 | 3.79 | 3.79 | 4.22 | 4.54 | 4.71 |
| ROIC %i | 4.08 | 4.32 | 4.32 | 4.86 | 5.20 | 5.43 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 27.78 | 27.68 | 27.22 | 27.89 | 28.66 | 29.05 |
| FCF / sales %i | 18.27 | 17.08 | 16.79 | 17.07 | 18.16 | 17.58 |
| Current ratioi | 0.45 | 0.68 | 0.63 | 0.64 | 0.52 | 0.46 |
| Quick ratioi | 0.27 | 0.42 | 0.39 | 0.41 | 0.32 | 0.29 |
| Debt / assetsi | 45.49 | 44.98 | 44.90 | 43.69 | 43.72 | 43.39 |
| LT debt / equityi | 97.55 | 103.22 | 102.11 | 98.06 | 95.01 | 93.88 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Natural Gas Pipelines is the largest reported line at 59.66% of revenue, across 5 reported segments.
- Products Pipelines follows at 20.15%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Natural Gas Pipelines59.66%
Products Pipelines20.15%
Terminals12.46%
Carbon dioxide (CO2)7.93%
Quote time 2026-10-08 08:04:16 · For reference only, not investment advice and not tailored to your situation.